Pulmonary Hypertension in Systemic Lupus Erythematosus Among Black and Hispanic Patients: An Observational Cohort Study
Miles King, Andreina Martinez, Samantha Abbruzzese, Melissa Fazzari, Atif Ameer, Muhammad A. Cheema, Valentin Marian, Muznay KhawajaObjective:
To determine clinical factors associated with pulmonary hypertension (PH) and assess its impact on clinical outcomes in a predominantly Black and Hispanic systemic lupus erythematosus (SLE) cohort from an underserved US urban setting.
Methods:
We conducted an observational cohort study of 140 adults with SLE treated at a large academic center in the Bronx, New York, from 2017 to 2021. PH was diagnosed by clinicians, supported by a right ventricular or pulmonary artery systolic pressure >35 mm Hg by echocardiography. The primary outcome was time to clinician-adjudicated lupus flare-related hospitalization. Secondary outcomes included hospitalization due to lupus flare with cardiac involvement and all-cause mortality. Cox proportional hazards models with PH as a time-varying covariate were used to assess associations.
Results:
At baseline, the following comorbidities were all significantly more common in patients with PH compared with those without interstitial lung disease (ILD) (22.9% vs. 8.7%;
Conclusions:
In this predominantly Black and Hispanic cohort with SLE, PH emerged as a clear, independent predictor of lupus flare-related hospitalizations. Vigilant PH screening and timely intervention may help reduce morbidity in high-risk, underserved SLE populations.